{"id":"NCT01193153","sponsor":"Janssen Scientific Affairs, LLC","briefTitle":"A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2013-10","completion":"2013-10","firstPosted":"2010-09-01","resultsPosted":"2015-01-05","lastUpdate":"2015-01-05"},"enrollment":667,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Schizoaffective Disorder"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"paliperidone palmitate","otherNames":[]}],"arms":[{"label":"001","type":"EXPERIMENTAL"},{"label":"002","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the efficacy of paliperidone palmitate compared with placebo in the delay of relapse of the symptoms of schizoaffective disorder. This study will also assess the safety and tolerability of paliperidone palmitate in patients with schizoaffective disorder.","primaryOutcome":{"measure":"Double-blind: Percentage of Participants Who Experienced Relapse","timeFrame":"Day 1 up to Month 15 of double blind relapse prevention period","effectByArm":[{"arm":"Paliperidone Palmitate","deltaMin":15.2,"sd":null},{"arm":"Placebo","deltaMin":33.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"0.002"},{"comp":"OG000 vs OG001","p":"0.021"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"0.012"},{"comp":"OG000 vs OG001","p":"0.006"},{"comp":"OG000 vs OG001","p":"0.238"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":13},"locations":{"siteCount":80,"countries":["United States","Bulgaria","India","Malaysia","Philippines","Romania","South Africa","Ukraine"]},"refs":{"pmids":["26934062","25562685"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":54,"n":667},"commonTop":["Insomnia","Akathisia","Weight Increased","Injection Site Pain","Headache"]}}